Digital Content 
NEWS #PharmaBuzz
01 Apr 2026
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/currax-expands-patient-access-to-fda-approved-obesity-treatment-with-peekdirect-302731360.html
12 Nov 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20251112850345/en/Oar-Health-Launches-Clutch-the-First-Ever-Fast-Acting-Mint-to-Treat-Alcohol-Use-Disorder
04 Nov 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/currax-announces-obesityweek-data-showing-that-contrave-helps-curb-cravings-and-offers-marked-effectiveness-in-certain-populations-with-obesity-302604348.html
28 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/currax-pharmaceuticals-to-spotlight-new-research-at-obesityweek-2025-highlighting-craving-control-behavioral-adherence-and-subpopulation-outcomes-with-contrave-302596289.html
23 Oct 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/currax-pharmaceuticals-llc-to-provide-contrave-at-no-cost-to-federal-employees-during-government-shutdown-302592592.html
03 Oct 2025
// REUTERS
https://www.reuters.com/legal/government/alkermes-sued-over-alleged-scheme-block-generic-vivitrol-2025-10-03/
Share